BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Liu M, Liu X, Zhong W, Li Y, Ran Y, Guo L, Chen X, Zhao J, Wang B, Zhou L. Bifidobacterium animalis ssp. Lactis 420 Mitigates Autoimmune Hepatitis Through Regulating Intestinal Barrier and Liver Immune Cells. Front Immunol. 2020;11:569104. [PMID: 33123141 DOI: 10.3389/fimmu.2020.569104] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Z, Pan X, Li L. Crosstalk between liver macrophages and gut microbiota: An important component of inflammation-associated liver diseases. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1070208] [Reference Citation Analysis]
2 Jin J, Jing N, Liu F, Wang R, Zhang Y, Yang J, Hou Y, Zhang H, Xie Y, Liu H, Ge S. Both live and heat-killed Bifidobacterium animalis J-12 alleviated oral ulcer of LVG golden Syrian hamsters by intervening intestinal flora structure.. [DOI: 10.21203/rs.3.rs-2292353/v1] [Reference Citation Analysis]
3 Hov JR, Karlsen TH. The microbiota and the gut–liver axis in primary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 2022. [DOI: 10.1038/s41575-022-00690-y] [Reference Citation Analysis]
4 Niu X, Zhang N, Li S, Li N, Wang R, Zhang Q, He J, Sun E, Kang X, Zhan J. Bifidobacterium animalis subsp. lactis MN-Gup protects mice against gut microbiota-related obesity and endotoxemia induced by a high fat diet. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.992947] [Reference Citation Analysis]
5 Xu M, Luo K, Li J, Li Y, Zhang Y, Yuan Z, Xu Q, Wu X. Role of Intestinal Microbes in Chronic Liver Diseases. Int J Mol Sci 2022;23:12661. [PMID: 36293518 DOI: 10.3390/ijms232012661] [Reference Citation Analysis]
6 Wang Z, Yang L, Tang H, Zhang K, Chen Q, Liu C, Guo Y, Li M, Guo Z, Li B. In vivo evidence of the prevents DSS-induced colitis of Lactiplantibacillus plantarum L15. Front Microbiol 2022;13:1028919. [DOI: 10.3389/fmicb.2022.1028919] [Reference Citation Analysis]
7 Liu Q, He W, Tang R, Ma X. Intestinal homeostasis in autoimmune liver diseases. Chin Med J (Engl) 2022;135:1642-52. [PMID: 36193976 DOI: 10.1097/CM9.0000000000002291] [Reference Citation Analysis]
8 Wang L, Cao Z, Zhang L, Li J, Lv W. The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective. Front Immunol 2022;13:923599. [DOI: 10.3389/fimmu.2022.923599] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Cheng Z, Yang L, Chu H. The Gut Microbiota: A Novel Player in Autoimmune Hepatitis. Front Cell Infect Microbiol 2022;12:947382. [DOI: 10.3389/fcimb.2022.947382] [Reference Citation Analysis]
10 Manzoor R, Ahmed W, Afify N, Memon M, Yasin M, Memon H, Rustom M, Al Akeel M, Alhajri N. Trust Your Gut: The Association of Gut Microbiota and Liver Disease. Microorganisms 2022;10:1045. [DOI: 10.3390/microorganisms10051045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Liwinski T, Heinemann M, Schramm C. The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts. Semin Immunopathol 2022. [PMID: 35536431 DOI: 10.1007/s00281-022-00936-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 李 玉. Relationship between Gut Microbiota and Development and Prognosis of Autoimmune Liver Disease. ACM 2022;12:10814-10821. [DOI: 10.12677/acm.2022.12111557] [Reference Citation Analysis]
13 Zheng Y, Ran Y, Zhang H, Wang B, Zhou L. The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes. Front Physiol 2021;12:715852. [PMID: 34690796 DOI: 10.3389/fphys.2021.715852] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
14 Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Shirokova E. Probiotics in hepatology: An update. World J Hepatol 2021;13:1154-66. [PMID: 34630882 DOI: 10.4254/wjh.v13.i9.1154] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
15 Wu J, Bortolanza M, Zhai G, Shang A, Ling Z, Jiang B, Shen X, Yao Y, Yu J, Li L, Cao H. Gut microbiota dysbiosis associated with plasma levels of Interferon-γ and viral load in patients with acute hepatitis E infection. J Med Virol 2022;94:692-702. [PMID: 34549810 DOI: 10.1002/jmv.27356] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Fan JH, Liu GF, Lv XD, Zeng RZ, Zhan LL, Lv XP. Pathogenesis of autoimmune hepatitis. World J Hepatol 2021; 13(8): 879-886 [PMID: 34552694 DOI: 10.4254/wjh.v13.i8.879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Miao Z, Lai Y, Zhao Y, Chen L, Zhou J, Li C, Wang Y. Protective Property of Scutellarin Against Liver Injury Induced by Carbon Tetrachloride in Mice. Front Pharmacol 2021;12:710692. [PMID: 34421606 DOI: 10.3389/fphar.2021.710692] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Chen T, Li R, Chen P. Gut Microbiota and Chemical-Induced Acute Liver Injury. Front Physiol 2021;12:688780. [PMID: 34122150 DOI: 10.3389/fphys.2021.688780] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
19 Zhang H, Liu M, Zhong W, Zheng Y, Li Y, Guo L, Zhang Y, Ran Y, Zhao J, Zhou L, Wang B. Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages via RIP3 Signaling Pathway in Autoimmune Hepatitis. Front Immunol 2021;12:624360. [PMID: 33841405 DOI: 10.3389/fimmu.2021.624360] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]